» Articles » PMID: 33297360

Mutations and Copy Number Alterations in Wild-Type Glioblastomas Are Shaped by Different Oncogenic Mechanisms

Abstract

Little is known about the mutational processes that shape the genetic landscape of gliomas. Numerous mutational processes leave marks on the genome in the form of mutations, copy number alterations, rearrangements or their combinations. To explore gliomagenesis, we hypothesized that gliomas with different underlying oncogenic mechanisms would have differences in the burden of various forms of these genomic alterations. This was an analysis on adult diffuse gliomas, but -mutant gliomas as well as diffuse midline gliomas -K27M were excluded to search for the possible presence of new entities among the very heterogenous group of -WT glioblastomas. The cohort was divided into two molecular subsets: (1) Molecularly-defined GBM (mGBM) as those that carried molecular features of glioblastomas (including promoter mutations, 7/10 pattern, or -amplification), and (2) those who did not (others). Whole exome sequencing was performed for 37 primary tumors and matched blood samples as well as 8 recurrences. Single nucleotide variations (SNV), short insertion or deletions (indels) and copy number alterations (CNA) were quantified using 5 quantitative metrics (SNV burden, indel burden, copy number alteration frequency-wGII, chromosomal arm event ratio-CAER, copy number amplitude) as well as 4 parameters that explored underlying oncogenic mechanisms (chromothripsis, double minutes, microsatellite instability and mutational signatures). Findings were validated in the TCGA pan-glioma cohort. mGBM and "Others" differed significantly in their SNV (only in the TCGA cohort) and CNA metrics but not indel burden. SNV burden increased with increasing age at diagnosis and at recurrences and was driven by mismatch repair deficiency. On the contrary, indel and CNA metrics remained stable over increasing age at diagnosis and with recurrences. Copy number alteration frequency (wGII) correlated significantly with chromothripsis while CAER and CN amplitude correlated significantly with the presence of double minutes, suggesting separate underlying mechanisms for different forms of CNA.

Citing Articles

A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression.

Ulgen E, Gerlevik U, Gerlevik S, Oktay Y, Sezerman O, Turcan S Acta Neuropathol Commun. 2024; 12(1):95.

PMID: 38877600 PMC: 11177509. DOI: 10.1186/s40478-024-01811-1.


Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma.

Johns D, Williams R, Smith C, Nadaminti P, Samarasinghe R Clin Transl Med. 2024; 14(2):e1560.

PMID: 38299304 PMC: 10831580. DOI: 10.1002/ctm2.1560.


Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of cluster genes and promotion of neuronal lineage.

Abdallah A, Cardona H, Gadd S, Brat D, Powla P, Alruwalli W Neurooncol Adv. 2023; 5(1):vdad003.

PMID: 36845293 PMC: 9950856. DOI: 10.1093/noajnl/vdad003.


Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification.

Vallee A, Lecarpentier Y, Vallee J Biomedicines. 2021; 9(6).

PMID: 34070746 PMC: 8229353. DOI: 10.3390/biomedicines9060619.

References
1.
Barker P . Double minutes in human tumor cells. Cancer Genet Cytogenet. 1982; 5(1):81-94. DOI: 10.1016/0165-4608(82)90043-7. View

2.
Wang C, Liang C . MSIpred: a python package for tumor microsatellite instability classification from tumor mutation annotation data using a support vector machine. Sci Rep. 2018; 8(1):17546. PMC: 6277498. DOI: 10.1038/s41598-018-35682-z. View

3.
Stichel D, Ebrahimi A, Reuss D, Schrimpf D, Ono T, Shirahata M . Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol. 2018; 136(5):793-803. DOI: 10.1007/s00401-018-1905-0. View

4.
Eckel-Passow J, Lachance D, Molinaro A, Walsh K, Decker P, Sicotte H . Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015; 372(26):2499-508. PMC: 4489704. DOI: 10.1056/NEJMoa1407279. View

5.
Louis D, Wesseling P, Aldape K, Brat D, Capper D, Cree I . cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020; 30(4):844-856. PMC: 8018152. DOI: 10.1111/bpa.12832. View